Abbott Laboratories (ABT)
88.41
-0.09
(-0.10%)
USD |
NYSE |
Jun 18, 16:00
88.59
+0.18
(+0.20%)
After-Hours: 20:00
Abbott Laboratories Cash from Operations (Quarterly) : 1.315B for March 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.315B |
| December 31, 2025 | 3.315B |
| September 30, 2025 | 2.787B |
| June 30, 2025 | 2.047B |
| March 31, 2025 | 1.417B |
| December 31, 2024 | 2.868B |
| September 30, 2024 | 2.705B |
| June 30, 2024 | 1.96B |
| March 31, 2024 | 1.025B |
| December 31, 2023 | 3.038B |
| September 30, 2023 | 1.877B |
| June 30, 2023 | 1.203B |
| March 31, 2023 | 1.143B |
| December 31, 2022 | 2.326B |
| September 30, 2022 | 2.78B |
| June 30, 2022 | 2.41B |
| March 31, 2022 | 2.065B |
| December 31, 2021 | 3.067B |
| September 30, 2021 | 2.701B |
| June 30, 2021 | 2.128B |
| March 31, 2021 | 2.637B |
| December 31, 2020 | 3.798B |
| September 30, 2020 | 2.066B |
| June 30, 2020 | 1.322B |
| March 31, 2020 | 715.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.416B |
| September 30, 2019 | 1.948B |
| June 30, 2019 | 1.06B |
| March 31, 2019 | 712.00M |
| December 31, 2018 | 1.765B |
| September 30, 2018 | 2.183B |
| June 30, 2018 | 1.244B |
| March 31, 2018 | 1.108B |
| December 31, 2017 | 1.64B |
| September 30, 2017 | 2.005B |
| June 30, 2017 | 1.351B |
| March 31, 2017 | 574.00M |
| December 31, 2016 | 1.17B |
| September 30, 2016 | 1.217B |
| June 30, 2016 | 909.00M |
| March 31, 2016 | -93.00M |
| December 31, 2015 | 828.00M |
| September 30, 2015 | 1.195B |
| June 30, 2015 | 941.00M |
| March 31, 2015 | 2.00M |
| December 31, 2014 | 1.238B |
| September 30, 2014 | 1.201B |
| June 30, 2014 | 900.00M |
| March 31, 2014 | 336.00M |
| December 31, 2013 | 1.625B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp. | 348.00M |
| DexCom, Inc. | 525.60M |
| Insulet Corp. | 113.80M |
| Intuitive Surgical, Inc. | 911.90M |
| MiniMed Group, Inc. | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -20.32B |
| Cash from Financing (Quarterly) | 17.31B |
| Free Cash Flow | 7.378B |
| Free Cash Flow Per Share (Quarterly) | 0.5243 |
| Free Cash Flow to Equity (Quarterly) | -19.00B |
| Free Cash Flow to Firm (Quarterly) | 993.30M |
| Free Cash Flow Yield | 4.77% |